| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |